Today: 19 May 2026
Rivian stock slips in premarket after UBS turns bearish — what could move RIVN next
15 January 2026
1 min read

Rivian stock slips in premarket after UBS turns bearish — what could move RIVN next

NEW YORK, Jan 15, 2026, 05:00 ET — Premarket

Rivian Automotive’s shares eased 0.2% to $17.47 in premarket trading on Thursday, after the stock sank 7.2% in the previous session. The slide followed a UBS downgrade that questioned whether optimism around the EV maker’s next model and software push is already in the price.

UBS analyst Joseph Spak cut Rivian to Sell from Hold and lifted his 12-month price target — his forecast for where the stock could trade — to $15 from $13, Barron’s reported. Spak wrote the stock had gone “too far too fast” and warned that expectations for the company’s R2 launch could set it up for disappointment. Rivian had climbed 44% over the past three months, and about 30% of analysts now rate the stock a sell, Barron’s said. Barron’s

The downgrades come as investors wait for Rivian’s next hard checkpoint: fourth-quarter and full-year results due Feb. 12 after markets close. Rivian delivered 42,247 vehicles in 2025, down about 18% from a year earlier, and is preparing to start delivering its lower-cost R2 SUV in the first half of 2026, Reuters reported.

Earlier this week, Wolfe Research analyst Emmanuel Rosner also downgraded the stock to Sell with a $16 target, arguing the company faces a near-term “catalyst vacuum” before autonomy-related benefits show up later. Rosner said Rivian needs a stronger focus on artificial intelligence, similar to Tesla, especially in autonomous driving and subscription-based services, Barron’s wrote. Barron’s

Rivian has also been reshuffling its leadership as it gears up for the R2, hiring Greg Revelle as chief customer officer to oversee sales, marketing and operations, WardsAuto reported.

Traders were busy in derivatives on Wednesday. Rivian options volume was running at roughly three times the daily average, with calls — contracts that profit if a stock rises — outnumbering puts by about 1.5 to 1, Charles Schwab’s daily options update said.

The stock swung through $17.07 to $18.25 on Wednesday before finishing at $17.50. It traded lower again early Thursday, but the premarket move was modest after the prior session’s drop.

But the downside case is not hard to sketch: any slip on quality or execution can hit sentiment fast in this name. Rivian is recalling 19,641 previously serviced R1S and R1T vehicles in the U.S. over an improperly reassembled rear toe link, the U.S. safety regulator said last week. The company was aware of one crash with minor injuries linked to the issue, Reuters reported.

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

19 May 2026
Recursion Pharmaceuticals shares fell 2.2% to $2.825 Tuesday, hitting a 52-week low of $2.77, after reporting first-quarter revenue of $6.47 million, down from $14.75 million a year earlier. Net loss narrowed to $117.5 million. Early clinical data for REC-1245 showed no dose-limiting toxicities in 16 solid-tumor patients. The company ended March with $665.2 million in cash.
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

19 May 2026
Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
BP stock slides in London as $5 billion write-down warning puts buyback in focus
Previous Story

BP stock slides in London as $5 billion write-down warning puts buyback in focus

TSMC jolts Wall Street futures higher as chip stocks pop before the open
Next Story

TSMC jolts Wall Street futures higher as chip stocks pop before the open

Go toTop